These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 32623649

  • 21. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 22. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 23. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
    Kallinich T, Wittkowski H, Keitzer R, Roth J, Foell D.
    Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
    [Abstract] [Full Text] [Related]

  • 24. The significance of urinary beta-2 microglobulin level for differential diagnosis of familial Mediterranean fever and acute appendicitis.
    Ugan Y, Korkmaz H, Dogru A, Koca YS, Balkarlı A, Aylak F, Tunc SE.
    Clin Rheumatol; 2016 Jul; 35(7):1669-72. PubMed ID: 26873102
    [Abstract] [Full Text] [Related]

  • 25. Possible effect of subclinical inflammation on daily life in familial Mediterranean fever.
    Ozçakar ZB, Yalçinkaya F, Yüksel S, Acar B, Gökmen D, Ekim M.
    Clin Rheumatol; 2006 Mar; 25(2):149-52. PubMed ID: 16172947
    [Abstract] [Full Text] [Related]

  • 26. Does Familial Mediterranean Fever Provoke Atherosclerosis in Children? Evaluation of Arterial Stiffness and Serum Endocan Levels.
    Türkuçar S, Yıldız K, Küme T, Açarı C, Dundar HA, Makay B, Kır M, Ünsal E.
    Clin Rheumatol; 2021 Oct; 40(10):4199-4206. PubMed ID: 33813620
    [Abstract] [Full Text] [Related]

  • 27. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
    Sgouropoulou V, Stabouli S, Trachana M.
    Clin Rheumatol; 2019 Sep; 38(9):2577-2584. PubMed ID: 31127463
    [Abstract] [Full Text] [Related]

  • 28. Plasma and platelet serotonin levels in familial Mediterranean fever.
    Onat AM, Ozçakar L, Oztürk MA, Uçar G, Ureten K, Dagli N, Kiraz S, Ertenli I, Calgüneri M.
    Clin Exp Rheumatol; 2007 Sep; 25(4 Suppl 45):S16-20. PubMed ID: 17949546
    [Abstract] [Full Text] [Related]

  • 29. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O.
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [Abstract] [Full Text] [Related]

  • 30. Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard.
    Panossian A, Hambartsumyan M, Panosyan L, Abrahamyan H, Mamikonyan G, Gabrielyan E, Amaryan G, Astvatsatryan V, Wikman G.
    Nitric Oxide; 2003 Sep; 9(2):103-10. PubMed ID: 14623176
    [Abstract] [Full Text] [Related]

  • 31. Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients.
    Bodakçi E, Yaşar Bilge NŞ, Ataş N, Armağan B, Satış H, Sarı A, Bilici Salman R, Kübra Yardımcı G, Babaoğlu H, Kılıç L, Öztürk MA, Göker B, Haznedaroğlu Ş, Kalyoncu U, Tufan A, Kaşifoğlu T.
    Turk J Med Sci; 2021 Aug 30; 51(4):1706-1711. PubMed ID: 33460325
    [Abstract] [Full Text] [Related]

  • 32. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy.
    Bonfrate L, Scaccianoce G, Palasciano G, Ben-Chetrit E, Portincasa P.
    Eur J Clin Invest; 2017 Sep 30; 47(9):622-629. PubMed ID: 28678379
    [Abstract] [Full Text] [Related]

  • 33. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach.
    Özen S, Sag E, Ben-Chetrit E, Gattorno M, Gül A, Hashkes PJ, Kone-Paut I, Lachmann HJ, Tsitsami E, Twilt M, Benedetti F, Kuemmerle-Deschner JB.
    Rheumatology (Oxford); 2021 Aug 02; 60(8):3799-3808. PubMed ID: 33331943
    [Abstract] [Full Text] [Related]

  • 34. The anemia of familial Mediterranean fever disease.
    Celkan T, Celik M, Kasapçopur O, Ozkan A, Apak H, Ocak S, Arisoy N, Yildiz I.
    Pediatr Hematol Oncol; 2005 Dec 02; 22(8):657-65. PubMed ID: 16251171
    [Abstract] [Full Text] [Related]

  • 35. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA, Kilic L, Akdogan A, Kiraz S, Kalyoncu U, Karadag O, Ertenli I, Dogan I, Calguneri M.
    J Clin Rheumatol; 2011 Oct 02; 17(7):358-62. PubMed ID: 21946459
    [Abstract] [Full Text] [Related]

  • 36. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
    Yalçinkaya F, Cakar N, Acar B, Tutar E, Güriz H, Elhan AH, Oztürk S, Kansu A, Ince E, Atalay S, Girgin N, Doğru U, Aysev D, Ekim M.
    Rheumatol Int; 2007 Apr 02; 27(6):517-22. PubMed ID: 17103173
    [Abstract] [Full Text] [Related]

  • 37. Assessment of vascular damage in children and young adults with Familial Mediterranean Fever.
    Vampertzi O, Papadopoulou-Legbelou K, Triantafyllou A, Koletsos N, Alataki S, Douma S, Papadopoulou-Alataki E.
    Rheumatol Int; 2022 Jan 02; 42(1):59-69. PubMed ID: 34739572
    [Abstract] [Full Text] [Related]

  • 38. Is Familial Mediterranean Fever a thrombotic disease or not?
    Demirel A, Celkan T, Kasapcopur O, Bilgen H, Ozkan A, Apak H, Arisoy N, Yildiz I.
    Eur J Pediatr; 2008 Mar 02; 167(3):279-85. PubMed ID: 17436016
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Tufan A, Haznedaroglu S.
    J Clin Rheumatol; 2020 Jan 02; 26(1):7-13. PubMed ID: 30048391
    [Abstract] [Full Text] [Related]

  • 40. Role of serum calprotectin in identifying familial Mediterranean fever attacks.
    Polat MG, Omma A, Gokcen N, Kilinckaya MF, Ozkan Karaahmetoglu S.
    Ir J Med Sci; 2024 Aug 02; 193(4):1901-1909. PubMed ID: 38478181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.